药物对比
Canagliflozin vs Acarbose
比较Canagliflozin（Invokana）与Acarbose（Precose）治疗2型糖尿病：机制、心血管/肾脏获益、副作用，以及基于患者因素哪种可能更合适。
此页面暂无可用的对比维度。
临床背景
This comparison typically arises for type 2 diabetes patients considering an SGLT2 inhibitor versus an older alpha-glucosidase inhibitor, especially with cardiovascular or renal risk.
结论
Canagliflozin usually offers broader benefits than Acarbose for most adults with type 2 diabetes, particularly those with heart or kidney disease, though individual factors decide suitability.
全部药物对比